February 15, 2022

The University of Cincinnati is joining a nationwide study to evaluate repurposed medications in the search for effective, safe treatments for mild-to-moderate COVID-19. Repurposed medications are those already approved by the U.S. Food and Drug Administration for other indications. ACTIV-6, “The Randomized Trial to Evaluate Efficacy of Repurposed Medications,” is a nationwide double-blind study expected to enroll nearly 15,000 participants from across the United States through its website.

February 21, 2022

In 2016, the Centers for Disease Control and Prevention (CDC) set opioid-prescribing guidelines for physicians. The idea was to offer doctors the best ways to protect people from an over-prescription of pain pills which had fueled the misuse of opioids and amplified cascading overdose deaths in the United States. While the goal was to protect patients, the impact was not all positive. In an article published by Cincinnati.com, Christine Wilder, MD, of the Department of Psychiatry and Behavioral Neuroscience at the UC College of Medicine and the director of the UC Health Addiction Sciences, was one of the experts cited.

February 22, 2022

Health experts in the United States are monitoring an increase in cases of bird flu in several states, including Indiana, Kentucky and Virginia. In January, the United States Department of Agriculture detected the first U.S. bird flu case after a hunted wild bird tested positive for the virus in Colleton County, South Carolina. Experts reported that it was the H5N1 strain, a highly pathogenic avian influenza virus (HPAI) — the same strain responsible for fatal poultry outbreaks across Europe and Asia in late 2021. In a story on the increase in bird flu published by Healthline, Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine was one of the experts cited.

February 24, 2022

Research from UC is examining a protein that plays a key role in heart failure. The study is funded by the National Heart, Lung, and Blood Institute for just over $2 million dollars for four years and is a second renewal of a previous grant given to Sakthivel Sadayappan, PhD, professor in the Division of Cardiovascular Health and Disease in the Department of Internal Medicine at the UC College of Medicine.

February 17, 2022

New UC research discovered a unique class of medications that act as blood thinners by inhibiting an enzyme in the genes of tick saliva. The research focused on novel direct thrombin inhibitors (DTI) from tick salivary transcriptomes, or messenger RNA molecules expressed by an organism. The result is the development of new anticoagulant medications that can be used to treat patients with a variety of coronary issues, including heart attacks. The study was published in Nature Communication.

November 7, 2022

Ann Romaker, MD, of the Division of Pulmonary, Critical Care and Sleep Medicine in the UC College of Medicine was interviewed by Fox19 about the end of daylight saving time this past weekend.

November 17, 2022

According to a report in early 2022 from the Centers for Disease Control and Prevention, more than 37 million people in the United States have diabetes, which is more than 11% of the population. Diabetes was the seventh leading cause of death in the United States in 2017 based on the death certificates in which diabetes was listed as the underlying cause of death. A newly launched University of Cincinnati partnership is aiming to put a dent in those numbers in Greater Cincinnati.

May 2, 2022

The University of Cincinnati's Alice Tang was featured in a Healio article discussing recently published research that administering an immunotherapy drug prior to surgery did not increase risks for patients with advanced oral cavity cancer.

May 3, 2022

New research out of the University of Cincinnati established the Kidney Transplant Equity Index, examining the number of minority patients transplanted at a kidney transplant center relative to the prevalence of minority patients on dialysis in each center’s health service area.

April 26, 2022

The University of Cincinnati's Hyacinth I. Hyacinth was featured in a Spectrum News story about his research into biological factors that contribute to racial health disparities in patients with dementia.